Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in Diabetic Macular Edema
NCT00768040Phase 2Terminated
- Sponsor
- Novartis
- Start
- Sep 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of aliskiren in diabetic macular edema (DME), sponsored by Novartis. Started Sep 2008; status: terminated.
02
Drugs
aliskiren
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00768040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768040.